EMA perspective on the value of model‐informed drug development for labeling recommendations regarding medicine use during pregnancy and breastfeeding.
Saved in:
| Title: | EMA perspective on the value of model‐informed drug development for labeling recommendations regarding medicine use during pregnancy and breastfeeding. |
|---|---|
| Authors: | Manolis, Efthymios1 (AUTHOR) efthymios.manolis@ema.europa.eu, Musuamba, Flora Tshinanu2,3 (AUTHOR), de Vries, Corinne S.1 (AUTHOR), Colin, Pieter J.1,4 (AUTHOR), Oleksiewicz, Martin B.5 (AUTHOR) |
| Source: | CPT: Pharmacometrics & Systems Pharmacology. Nov2024, Vol. 13 Issue 11, p1820-1823. 4p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 21638306 |
|---|---|
| DOI: | 10.1002/psp4.13214 |
